Digital health for chronic disease management: An exploratory method to investigating technology adoption potential
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0284477 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Vasileios Nittas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics & Prevention Institute, Epidemiology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Technology, Biomedical Technology. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Multiple Sclerosis Society.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Introduction
The availability of consumer-facing health technologies for chronic disease management is skyrocketing, yet most are limited by low adoption rates. Improving adoption requires a better understanding of a target population’s previous exposure to technology. We propose a low-resource approach of capturing and clustering technology exposure, as a mean to better understand patients and target health technologies.
Methods
Using Multiple Sclerosis (MS) as a case study, we applied exploratory multivariate factorial analyses to survey data from the Swiss MS Registry. We calculated individual-level factor scorings, aiming to investigate possible technology adoption clusters with similar digital behavior patterns. The resulting clusters were transformed using radar and then compared across sociodemographic and health status characteristics.
Results
Our analysis included data from 990 respondents, resulting in three clusters, which we defined as the (1) average users, (2) health-interested users, and (3) low frequency users. The average user uses consumer-facing technology regularly, mainly for daily, regular activities and less so for health-related purposes. The health-interested user also uses technology regularly, for daily activities as well as health-related purposes. The low-frequency user uses technology infrequently.
Conclusions
Only about 10% of our sample has been regularly using (adopting) consumer-facing technology for MS and health-related purposes. That might indicate that many of the current consumer-facing technologies for MS are only attractive to a small proportion of patients. The relatively low-resource exploratory analyses proposed here may allow for a better characterization of prospective user populations and ultimately, future patient-facing technologies that will be targeted to a broader audience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Biostatistics & Prevention Institute, Epidemiology, University of Zurich, Zurich, Switzerland.
- Department of Health Sciences and Technology, Health Ethics and Policy Lab, ETH Zurich, Zurich, Switzerland.
- Department of Neurology, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.
- Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
- Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
- Neurology and Neurorehabilitation Center, Luzerner Kantonsspital, Lucerne, Switzerland.
ORCID-Profile: Vasileios Nittas, Chiara Zecca, Christian P Kamm
Förderung
- Swiss Multiple Sclerosis Society
Zitieren
APA
Nittas, V., Zecca, C., Kamm, C. P., Kuhle, J., Chan, A., & von Wyl, V. (2023). Digital health for chronic disease management: An exploratory method to investigating technology adoption potential. PLOS ONE. https://doi.org/10.1371/journal.pone.0284477
Vancouver
Nittas V, Zecca C, Kamm CP, Kuhle J, Chan A, von Wyl V. Digital health for chronic disease management: An exploratory method to investigating technology adoption potential. PLOS ONE. 2023. doi:10.1371/journal.pone.0284477
BibTeX
@article{Nittas2023,
author = {Nittas, Vasileios and Zecca, Chiara and Kamm, Christian P and Kuhle, Jens and Chan, Andrew and von Wyl, Viktor},
title = {Digital health for chronic disease management: An exploratory method to investigating technology adoption potential},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0284477}
}
EUVIMED